XML 79 R3.htm IDEA: XBRL DOCUMENT

Award Timing Disclosure
$ / shares in Units, $ in Millions

12 Months Ended

Dec. 28, 2024

Feb. 26, 2024

USD ($)

$ / shares

Award Timing Disclosures [Line Items]

The Compensation Committee and senior management monitor the Company’s equity grant practices to evaluate whether such policies comply with governing regulations and are consistent with good corporate practices. When making regular annual equity grants, the Compensation Committee’s practice is to approve them at its meeting in February of each year as part of the annual compensation review and after results for the preceding fiscal year become available. Because the Compensation Committee’s regular meeting schedule is determined in the prior fiscal year, the proximity of any awards to other significant corporate events is coincidental. In addition, the Compensation Committee may make grants at any time during the year it deems appropriate, including with respect to new hires, promotions or role transitions. We attempt to make equity awards during periods when we do not have material non-public information (“MNPI”) that could impact our stock price and we do not time the release of MNPI based on equity grant dates.

The Compensation Committee has established a pool of shares from which the Chief Executive Officer is authorized to make discretionary equity awards to any employee of the Company, other than “covered employees,” officers, directors of other persons subject to Section 16 of the Exchange Act. The Company's practice is to make such awards on a quarterly basis approximately two weeks following the Company's quarterly earnings announcement.

During 2024, the annual stock option grant was made to our NEOs during the period beginning four business days before the filing or furnishing of a periodic report or current report and ending one business day after the filing or furnishing of any such report with the SEC, as set forth below:


Name	Grant Date (1)	Number of Securities Underlying the Award		Exercise Price of the Award ($/Sh)		Grant Date Fair Value of the Award		Percentage Change in the Closing Market Price of the Securities Underlying the Award Between the Trading Day Ending Immediately Prior to the Disclosure of Material Nonpublic Information and the Trading Day Beginning Immediately Following the Disclosure of Material Nonpublic Information
Nicholas I. Fink	2/26/2024		81,324	$	79.83	$	2,124,996	1.3%
David V. Barry	2/26/2024		15,308	$	79.83	$	399,998	1.3%
Cheri M. Phyfer	2/26/2024		22,866	$	79.83	$	597,489	1.3%
John D. Lee	2/26/2024		10,524	$	79.83	$	274,992	1.3%
Hiranda S. Donoghue	2/26/2024		10,285	$	79.83	$	268,747	1.3%

(1) The Company’s Annual Report on Form 10-K for the period ended December 31, 2023 was filed on February 27, 2024, with the Company’s press release announcing the Company’s financial results for the same period released on January 30, 2024.

Award Timing MNPI Considered

false

Award Timing, How MNPI Considered

When making regular annual equity grants, the Compensation Committee’s practice is to approve them at its meeting in February of each year as part of the annual compensation review and after results for the preceding fiscal year become available. Because the Compensation Committee’s regular meeting schedule is determined in the prior fiscal year, the proximity of any awards to other significant corporate events is coincidental. In addition, the Compensation Committee may make grants at any time during the year it deems appropriate, including with respect to new hires, promotions or role transitions. We attempt to make equity awards during periods when we do not have material non-public information (“MNPI”) that could impact our stock price and we do not time the release of MNPI based on equity grant dates.

MNPI Disclosure Timed for Compensation Value

false

Awards Close in Time to MNPI Disclosures, Table


Name	Grant Date (1)	Number of Securities Underlying the Award		Exercise Price of the Award ($/Sh)		Grant Date Fair Value of the Award		Percentage Change in the Closing Market Price of the Securities Underlying the Award Between the Trading Day Ending Immediately Prior to the Disclosure of Material Nonpublic Information and the Trading Day Beginning Immediately Following the Disclosure of Material Nonpublic Information
Nicholas I. Fink	2/26/2024		81,324	$	79.83	$	2,124,996	1.3%
David V. Barry	2/26/2024		15,308	$	79.83	$	399,998	1.3%
Cheri M. Phyfer	2/26/2024		22,866	$	79.83	$	597,489	1.3%
John D. Lee	2/26/2024		10,524	$	79.83	$	274,992	1.3%
Hiranda S. Donoghue	2/26/2024		10,285	$	79.83	$	268,747	1.3%